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To understand the adaptation of Mycobacterium
tuberculosis to the intracellular environment, we
used comprehensive metabolite profiling to identify
the biochemical pathways utilized during growth on
cholesterol, a critical carbon source during chronic
infection. Metabolic alterations observed during
cholesterol catabolism centered on propionyl-CoA
and pyruvate pools. Consequently, growth on this
substrate required the transcriptional induction of
the propionyl-CoA-assimilating methylcitrate cycle
(MCC) enzymes, via the Rv1129c regulatory protein.
We show that both Rv1129c and the MCC enzymes
are required for intracellular growth in macrophages
and that the growth defect of MCCmutants is largely
attributable to the degradation of host-derived cho-
lesterol. Together, these observations define a coor-
dinated transcriptional and metabolic adaptation
that is required for scavenging carbon during intra-
cellular growth.
INTRODUCTION
The physiological state of intracellular pathogens is inextricably
linked to the host cell in which they reside, and each pathogen
is metabolically adapted to its specific niche. Nutrition is a
primary factor driving this adaption, as each pathogen is
forced to subsist on locally available host-derived compounds.
Intraphagosomal pathogens, like Mycobacterium tuberculosis,
must acquire nutrients while surrounded by a host-derived
membrane (Appelberg, 2006). Perhaps because of this
sequestration, M. tuberculosis is thought to utilize these
surrounding host lipids as carbon sources (Russell et al.,
2010).
The preferential use of lipid carbon sources byM. tuberculosis
in vivo has been inferred from the transcriptional induction of
genes encoding fatty acid degradation enzymes (Schnappinger
et al., 2003) and from the requirement for specific pathways in
central carbon metabolism (Marrero et al., 2010; McKinney218 Chemistry & Biology 19, 218–227, February 24, 2012 ª2012 Elseet al., 2000) that are often essential for the utilization of nonglyco-
lytic carbon sources. The identity of specific host lipids used
byM. tuberculosis remained elusive until a dedicated cholesterol
uptake and catabolic pathway was identified in the bacterium
(Van der Geize et al., 2007). The subsequent demonstration
that both cholesterol uptake and degradation are necessary for
growth and survival of M. tuberculosis in chronically infected
mice (Nesbitt et al., 2010; Pandey and Sassetti, 2008) verified
that this single component of host membranes is an essential
nutrient during chronic infection.
Despite these observations, it remained unclear whether
cholesterol catabolism contributes significantly to the central
metabolic requirements for growth in the complex host environ-
ment. Although cholesterol is catabolized to some extent
throughout infection (Chang et al., 2009), cholesterol uptake
mutants grow normally before the onset of adaptive immunity
in mice and in the resting macrophages that characterize this
stage of infection (Pandey and Sassetti, 2008). These observa-
tions indicate that additional carbon sources are available to
the bacterium in vivo, such as fatty acids, sugars, and amino
acids. In addition, environmental conditions encountered
during infection, including altered O2, CO, NO, and H
+ concen-
trations (Chan et al., 1995; Kumar et al., 2008; Rohde et al.,
2007; Via et al., 2008), could contribute to metabolic alter-
ations. To begin to understand the specific role of nutrition in
the overall metabolic adaptation to the host, we sought to
understand how the only defined in vivo carbon source, choles-
terol, influenced the physiology of the bacterium during
infection.
To do this, we used comprehensive metabolite profiling to
characterize the metabolic state of M. tuberculosis during
growth on defined carbon sources. Utilization of cholesterol
profoundly altered the abundance of a variety of primary metab-
olites, most notably the intermediates of a propionyl-CoA
catabolic pathway known as the methylcitrate cycle (MCC).
The activity of this pathway appeared to be rate limiting for
growth under these conditions, as transcriptional induction of
the dedicated enzymatic steps was essential. While propionyl-
CoA can be derived from a variety of host components other
than cholesterol, we demonstrate that the requirement for this
metabolic pathway in vivo is largely attributable to the utilization
of this single host carbon source.vier Ltd All rights reserved
Figure 1. Growth on Cholesterol Causes
Metabolic Changes Consistent with
Increased MCC Flux
Quadruplicate samples of Mtb were grown with
either cholesterol or glycerol as primary carbon
sources, and LC/MS and GC/MS were used to
quantify the relative abundance of primary
metabolites.
(A) The average relative abundance of each
metabolite in glycerol- or cholesterol-grown
bacteria is plotted. Subsets of the differentially
abundant metabolites are shown in red or green to
represent their accumulation in either cholesterol-
or glycerol-fed cultures, respectively. These
metabolites are highlighted in the same colors in
(B) and described in Table 1.
(B) Differentially represented metabolites indicate
increased MCC flux and are shown in relation to
the relevant carbon metabolic pathways. Both the
MCC and the glyoxylate cycle (GC) are highlighted
in blue. The predicted catabolism of cholesterol
into acetyl-CoA, propionyl-CoA, and pyruvate
(Van der Geize et al., 2007) is indicated. The B12-
dependent methylmalonyl CoA mutase (MCM) is
also shown. See Tables S1 and S2 for details
regarding metabolite quantification and identifi-
cation, respectively.
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Metabolomic Profile of Cholesterol Catabolism
The dedicated pathway responsible for the degradation of
cholesterol into primary metabolites remains to be completelyChemistry & Biology 19, 218–227, February 24, 2012elucidated, but the catabolism of this
compound is predicted to produce an
ill-defined mixture of propionyl-CoA,
acetyl-CoA, and pyruvate (Van der Geize
et al., 2007). To characterize the central
metabolic consequences of growth on
this sterol, M. tuberculosis was grown in
minimal media containing either choles-
terol or glycerol, carbon sources that are
initially catabolized by distinct pathways
(Figure 1). Liquid- and gas-chromatog-
raphy-coupled mass spectrometry was
then used to globally profile metabolite
pools in each population. Individual
metabolites were identified by compar-
ison to a library of retention times and
masses of authentic standards, and the
relative abundance of each metabolite
was determined with respect to carbon
source.
This analysis unambiguously identified
146 distinct metabolites, which were
distributed throughout amino acid,
carbohydrate, lipid, nucleotide, cofactor,
and central carbon metabolism (Table
S1 available online). Overall, metabolite
levels were comparable betweenthese two cultures (Figure 1A), which is consistent with the
similar doubling times observed in these media (Pandey and
Sassetti, 2008). Statistical analysis of these data identified 29
metabolites that accumulated to a significant degree in the
cholesterol-grown cells. (Table 1 and Table S1). Among theseª2012 Elsevier Ltd All rights reserved 219
Table 1. Metabolites that Significantly Accumulated following
Growth on Cholesterol
Biochemical Name
Cholesterol/
Glycerol Ratioa p Value
Tryptophan 2.07 0.0226
2-Aminoadipate 5.54 0.0022
Alanine 2.02 0.027
Beta-alanine 4.44 0.0098
Lysine 3.39 0.0424
Pipecolate 2.15 0.023
S-adenosylhomocysteine (SAH) 1.85 0.0432
Threonine 2.86 0.0218
Isoleucine 2.33 0.0376
Methylsuccinate 16.28 <0.001
Histidine 2.9 0.0195
N-acetylornithine 2.19 0.0079
Serine 2.81 0.0259
Gamma-glutamylthreonine 1.9 0.0205
Adenosine-50-diphosphoglucose 3.45 0.0103
Mannose 4.02 0.0494
Mannose-1-phosphate 5.34 0.0125
Trehalose 6-phosphate 5.17 0.0224
2-Methylcitrate 22.81 <0.001
Citrate 4.02 0.0054
Fumarate 2.95 0.0371
Malate 5.49 0.012
Succinate 4.67 0.0022
Adenosine 50-monophosphate (AMP) 1.73 0.0305
Thymidine 50-monophosphate 3.38 0.0294
Pantothenate 5 0.0024
Nicotinate 3.66 0.0264
Nicotinate ribonucleoside 2.91 0.0338
Nicotinic acid mononucleotide (NaMN) 2.2 0.0011
a This column represents the relative abundance of each species in the
indicated media. The p values were calculated as described in Experi-
mental Procedures.
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trate. These compounds account for four of the six intermedi-
ates of the MCC, a variant of the tricarboxylic acid cycle
used for the conversion of propionyl-CoA into pyruvate (Pronk
et al., 1994; Textor et al., 1997). The remaining two intermedi-
ates were not detected under either condition. Consistent
with increased activity of the MCC, we also found an accumu-
lation of amino acids derived from the MCC intermediate
oxaloacetate (OAA) and the MCC product, pyruvate (Figure 1B).
Pyruvate may also be directly liberated from the cholesterol
steroid nucleus during catabolism (Van der Geize et al.,
2007), further increasing the abundance of this compound.
This analysis suggests that propionyl-CoA and pyruvate
metabolism are central for the adaptation of M. tuberculosis
to growth on cholesterol, and these metabolites are linked via
the MCC.220 Chemistry & Biology 19, 218–227, February 24, 2012 ª2012 ElsePropionyl-CoA Is Liberated from the Side Chain
of Cholesterol
In addition to fueling the MCC, propionyl-CoA can also be used
as a precursor for methyl branched-chain lipid synthesis after
conversion to methylmalonyl CoA (Jain et al., 2007). We have
previously shown that carbon derived from the branched side
chain of cholesterol was efficiently incorporated intomycobacte-
rial lipids (Pandey and Sassetti, 2008), making the side chain
terminus a likely source of propionyl-CoA. To directly investigate
themetabolic fate of this moiety, we analyzed the composition of
the cellular lipids labeled after growth in cholesterol containing
a 14C label at the terminus of its side chain (Figure 2A). Upon
profiling the total polar lipid extract, we found that a single
species incorporated more than 80% of the 14C derived from
[26-14C]-cholesterol, in contrast to [1,2-14C]-acetate, which
labeled a variety of other lipids. Mass spectrometry was used
to identify this species as sulfolipid-1 (SL-1), one of the promi-
nent methyl branched-chain lipids of M. tuberculosis (Figure 2).
Another major branched-chain lipid previously shown to incor-
porate propionate-derived carbon, phthiocerol dimycocerosate,
was not present in this extract.
Because both the abundance and chain length of SL-1 are
directly related to availability of the propionyl-CoA precursor
(Jain et al., 2007), we used these metrics to estimate the abun-
dance of this precursor metabolite in cholesterol-grown cells.
We found that both the molecular weight of SL-1 and its relative
abundance, compared to other unrelated ions in the mass spec-
trum, increased in cholesterol-grown cultures (Figure 2C). This
observation was consistent with the cholesterol-induced
increase in length and abundance of phthiocerol dimycocero-
sate (Yang et al., 2009; data not shown), which is synthesized
from the same precursor pool. The preferential flux of cholesterol
side-chain-derived carbon into SL-1 and the inferred increase in
methylmalonyl CoA in cholesterol-grown cells both indicate that
cholesterol is a significant source of propionyl-CoA and that
at least a portion of this metabolite is derived from the side
chain terminus.
Functional MCC Enzymes Are Required for Growth
in the Presence of Cholesterol
To determine the importance of propionyl-CoA metabolism
during growth on cholesterol, we tested the ability of MCC-
deficient mutants to grow using this carbon source. We found
that the deletion of the prpC and prpD genes, encoding the two
dedicated steps of this pathway, specifically impaired the bacte-
rium’s ability to grow inmedia containing cholesterol as a primary
carbon source (Figures 3A and 3B). Similarly, deletion of the icl1
gene, which encodes a bifunctional methylisocitrate lyase and
isocitrate lyase (MCL/ICL) that is necessary for both the MCC
and glyoxylate cycles (Gould et al., 2006), caused a specific
growth defect in cholesterol-containing media (Figures 3E and
3F). Deletion of the partially redundant icl2 gene, either alone or
in combination with the icl1mutation, had a more modest effect.
In many bacteria, including mycobacteria, the inability to
assimilate propionyl-CoA inhibits growth even in the presence
of other carbon sources (Mun˜oz-Elı´as et al., 2006; Savvi et al.,
2008). This is likely due to the accumulation of intermediates
that inhibit other essential pathways (Rocco and Escalante-
Semerena, 2010). Indeed, when we cultured DprpDC or Dicl1vier Ltd All rights reserved
Figure 2. Cholesterol Side-Chain-Derived
Propionate Is Incorporated into SL-1 and
Increases the Mass of This Lipid
(A) The cholesterol molecule. Carbon 26 is indi-
cated.
(B) Total polar lipids were extracted from [26-14C]
cholesterol-fed (lane 1) and [1,2-14C]acetate-fed
(lane 2) bacteria, separated by thin layer chroma-
tography, and detected by autoradiography.
(C) The major species labeled by cholesterol was
isolated and identified as SL-1 using ESI-TOF MS.
The m/z peaks depicted match the previously
described lipoforms of SL-1 (Kumar et al., 2007).
TLC-purified samples of SL-1 from cholesterol-fed
and from glycerol-fed bacteria were compared to
demonstrate that growth on cholesterol increased
the mass of SL-1.
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we observed growth defects that were comparable to the
single-carbon-source media (Figures 3C and 3G). To verify that
this growth defect was due to propionyl-CoA-related toxicity,
we enabled an alternative assimilation system, the methylma-
lonyl pathway (MMP). This pathway converts propionyl-CoA
into succinyl-CoA via the B12-dependent methylmalonyl CoA
mutase (MCM) enzyme (Figure 1B), allowing MCC mutants to
grow on propionyl-CoA-generating substrates (Savvi et al.,
2008). Because M. tuberculosis is unable to synthesize B12
under these conditions, theMMP is only active uponB12 supple-
mentation. As anticipated, the addition of B12 to these mixed-
carbon-source cultures reversed the growth defect imparted
by MCC mutations (Figures 3D and 3H). The modest residual
defect of the Dicl1 mutant in media containing only cholesterol
may be attributable to the additional role played by this enzymeChemistry & Biology 19, 218–227, February 24, 2012in another tricarboxylic acid cycle variant,
the glyoxylate shunt. We conclude that
propionyl-CoA metabolism is essential
for growth in the presence of cholesterol.
Transcriptional Induction of MCC
Genes by Rv1129c Is Required for
Propionyl-CoA Metabolism In Vitro
The accumulation of MCC intermediates
during the growth of M. tuberculosis on
cholesterol suggested that the activity
of the dedicated MCC enzymes may
be increased under these conditions.
Indeed, we found that the abundance of
the mRNA encoding both prpC and
prpD was increased fivefold in choles-
terol-grown cultures (Figure 4). The
rv1129c gene appeared to be divergently
transcribed from the prpDC operon and
encoded a protein that was 47% identical
to RamB, the regulator of icl gene tran-
scription in actinobacteria (Gerstmeir
et al., 2004; Micklinghoff et al., 2009).
This suggested that Rv1129c may
perform a function similar to that of thehomologous RamB and regulate the transcription of prpDC. To
investigate this, we compared the level of prpDC mRNA in
wild-type bacteria with a strain in which the rv1129c gene had
been deleted. We found that transcript levels of both prpD and
prpC were dramatically reduced in the absence of rv1129c,
regardless of carbon source, and that this phenotype could be
complemented in trans by expressing a wild-type copy of the
gene (Figure 4B).
To understand the physiological relevance of this regulation,
we determined if the deletion of rv1129c would alter growth
on propionyl-CoA-generating substrates. We found that the
rv1129c mutant was unable to grow using either propionate or
cholesterol as a primary carbon source (Figures 4C and 4E).
This phenotype was rescued either by genetic complementation
or by adding B12 to circumvent the MCC requirement (Figures
4D and 4F), demonstrating that transcriptional induction ofª2012 Elsevier Ltd All rights reserved 221
Figure 3. The MCC Is Required for the
Metabolism of Cholesterol-Derived Propio-
nate
The indicatedmutants were grown in the presence
of 0.1% glycerol (A and E), 0.01% cholesterol
(B and F), or 0.01% cholesterol and 0.1% glycerol
(C and G) as primary carbon sources. Vitamin B12
supplementation (D and H) allowed all mutants
to grow using cholesterol. Optical density was
measured at the indicated time points and is
plotted on a log scale. prpDC mutants were
generated in the H37Rv strain, and icl1/2 mutants
were derived from the Erdman strain.
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derived propionate.
Cholesterol Is a Significant Source of the Propionyl-CoA
Generated during Intracellular Growth
The dedicated MCC components PrpD and PrpC, as well as the
multifunctional MCL/ICL enzymes, are required for intracellular
growth in macrophages (Mun˜oz-Elı´as and McKinney, 2005;
Mun˜oz-Elı´as et al., 2006), indicating that propionyl-CoAmetabo-
lism is critical in this niche. To determine if this requirement could
be attributed directly to cholesterol catabolism, we investigated
the contribution of cholesterol-derived propionyl-CoA to this
phenotype.
First, we sought to determine whether the previously de-
scribed intracellular growth defect of MCC mutants was due to
propionyl-CoA-related toxicity. To do this, we infected bone-
marrow-derived macrophages (BMDMs) with M. tuberculosis
and inhibited the MCC by genetic deletion of prpDC or chemical
inhibition of MCL/ICL activity with 3-nitropropionate (3-NP)
(Schloss and Cleland, 1982). Both MCC inhibition strategies re-
sulted in a significant inhibition of intracellular growth. Addition
of B12 to enable the alternative MMP caused a dose-dependent
reversal of both phenotypes (Figures 5A and 5B), indicating that
propionyl-CoA-related toxicity was the basis for these growth
defects. Similarly, we found that the rv1129c regulatory mutant
was unable to grow in BMDM unless supplemented with B12,
indicating that this protein contributes to intracellular growth
largely by inducing the expression of MCC enzymes (Figure 5C).
We then investigated whether cholesterol contributed signifi-
cantly to the bacterial propionyl-CoA pool during intracellular
growth. To do this, we used M. tuberculosis mutants lacking
the Mce4 cholesterol uptake system, which imports cholesterol
at a greatly reduced rate but grows normally in resting BMDM
(Mohn et al., 2008; Pandey and Sassetti, 2008). To estimate
the propionyl-CoA pool in wild-type and mce4 mutants during
intracellular growth, we compared the relative sensitivity of these
strains to Icl1/2 inhibition with 3-NP. The cholesterol uptake
mutants were significantly more resistant to 3-NP, indicating
that less MCL/ICL activity was necessary and, therefore, that
less propionyl-CoA was generated in the absence of cholesterol
catabolism (Figure 5D). To further support this conclusion, we
determined if the mce4 deletion was also able to suppress the
growth defect of the DprpDC mutant. Indeed, we observed222 Chemistry & Biology 19, 218–227, February 24, 2012 ª2012 Elsethat Dmce4/DprpDC double mutants grew significantly more
rapidly than DprpDC single mutants in BMDM, and that the
residual growth defect of the double mutants could be fully
reversed by the addition of B12 (Figure 5E). We conclude that
MCC mutants are unable to grow intracellularly because of pro-
pionyl-CoA toxicity, and a significant fraction of this metabolite is
produced via the catabolism of host cholesterol.
DISCUSSION
Many approaches have been used to determine how the intra-
cellular environment influences the physiological state of a
pathogen during infection. Most identify biochemical pathways
that are expressed or are essential during infection, and this
information is used to infer both the metabolic state of the
bacterium and the environment that imposes this state.
However, the complexity of metabolic networks makes these
inferences difficult, as a single enzyme can participate in multiple
biochemical pathways, and the reliance on any pathway can be
influenced by a number of different environmental factors. In this
work, we used a unique combination of direct metabolomic
profiling and genetic epistasis analysis to functionally connect
a distinct feature of the intracellular environment with its meta-
bolic consequence in the pathogen.
To understand the central metabolic adaptations required
for the utilization of the host-derived carbon source, cholesterol,
we globally surveyed the steady-state levels of primary metabo-
lites during growth on this compound. This approach is funda-
mentally different from more commonly used profiling of mRNA
or protein levels, which may not correlate with the metabolite
levels (Jozefczuk et al., 2010). We found that the differential
utilization of a pathway could be predicted by the abundance
of both its specific intermediates and itsmore stable biosynthetic
products. Labeling of proteinogenic amino acids has been used
extensively to predict the flux through central carbon metabo-
lism (Zamboni et al., 2009), and our data suggest that pool sizes
of individual amino acids are also likely stable enough to serve
this purpose. Together, these data provided a holistic view of
cellular metabolism and allowed us to identify pathways that
were critical for cholesterol catabolism.
The relatively dramatic accumulation of the PrpD substrate,
methylcitrate, suggested that the expression of this enzyme
might be insufficient for the flux of propionyl-CoA derived fromvier Ltd All rights reserved
Figure 4. The Transcriptional Activation of
MCC Genes by Rv1129c Is Required for
Growth on Cholesterol
(A) Genomic organization of rv1129c and the
prpDC genes.
(B) Rv1129c was required for both basal prpDC
expression and for the induction of these genes in
cholesterol media. Quantitative PCR was used to
measure the relative abundance of prpD and prpC
mRNA after 48 hr of growth in either 0.01%
cholesterol or 0.1% glycerol as primary carbon
sources. Error bars indicate standard deviation of
triplicate samples.
(C–F) Rv1129c is required for growth on propionyl-
CoA-generating substrates. Bacteria were cul-
tured in the indicated defined primary carbon
sources with or without vitamin B12, and growth
was monitored by optical density. Data are
representative of three independent experiments.
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liberated from each cholesterol molecule. In addition to the
terminal side-chain carbons, at least two other propionyl-CoA
molecules may be produced (Van der Geize et al., 2007), sug-
gesting that as much as one third of the carbon derived from
cholesterol could enter the MCC. While cholesterol appears to
be a significant source of propionyl-CoA, the incomplete sup-
pression of the DprpDC mutant’s intracellular growth defect by
Mce4 mutation indicates that either Mce4-independent choles-
terol uptake pathways operate in this environment or that
alternative carbon sources, such as odd-chain fatty acids or
branched-chain amino acids, also contribute to the propionyl-
CoA pool during infection.
The increased reliance on the MCC pathway during choles-
terol catabolism was confirmed by demonstrating that transcrip-
tional induction of the prpDC genes via the Rv1129c protein was
required for growth. The DNA-binding function of the homolo-
gous RamB protein of Corynebacterium glutamicum is post-
translationally regulated (Cramer et al., 2007; Micklinghoff
et al., 2009), perhaps via binding of an intermediary metabolite.
Thus, mycobacteria appear to use very similar regulatoryChemistry & Biology 19, 218–227, February 24, 2012proteins to control the pathways neces-
sary for propionyl- and acetyl-CoA catab-
olism, and differential expression of these
systems could be mediated via distinct
allosteric regulation.
Consistent with previous observations
(Mun˜oz-Elı´as et al., 2006; Savvi et al.,
2008), we found that the growth of
mutants lacking sufficient MCC activity
was inhibited by propionate, even in the
presence of an additional carbon source.
Several mechanisms have been pro-
posed to mediate propionyl-CoA-related
toxicity. For example, this metabolite
has been shown to inhibit pyruvate dehy-
drogenase (PDH) and citrate synthase in
other bacteria (Brock and Buckel, 2004;
Man et al., 1995; Maruyama and Kita-mura, 1985). While the accumulation of glycolytic intermediates
we observed in cholesterol-grown mycobacteria could be
consistent with these mechanisms, it is unclear whether the
unusual PDH complex (Tian et al., 2005) or the apparently redun-
dant citrate synthase enzymes (CitA and GltA) of mycobacteria
are inhibited by propionyl-CoA. Similarly, propionate-related
toxicity in MCC-deficient Salmonella is due to the accumulation
of a specific 2-methylcitrate isomer that inhibits the gluconeo-
genic enzyme, fructose 1,6 bisphosphatase (Rocco and
Escalante-Semerena, 2010). However, the type II fructose bi-
sphosphatase expressed by Mtb bears little resemblance to
the Salmonella enzyme. Thus, while abundant examples of this
phenomenon have been reported, it is currently unclear whether
these previously described mechanisms are relevant in
mycobacteria.
These metabolic insights provided the information necessary
to test whether the MCC requirement during intracellular growth
was due to host cholesterol utilization. The ability ofmce4muta-
tion to alleviate the intracellular growth defect produced by either
prpDC mutation or MCL/ICL inhibition implicates cholesterol as
a major source of propionate in vivo, even under conditions inª2012 Elsevier Ltd All rights reserved 223
Figure 5. Cholesterol Is an Intracellular
Source of Propionate
(A and B) MCC activity is required for propionyl-
CoA metabolism during intracellular growth.
BMDM were infected with H37Rv or the indicated
mutant strains. The MCC was inhibited either by
addition of 3NP to block MCL/ICL activity (A) or by
genetic deletion of the prpDC genes (B). Vitamin
B12was added to enable theMMP. The number of
intracellular bacteria at Day 6 postinfection are
plotted relative to the number of initial cell-asso-
ciated colony-forming units (cfu).
(C) Transcriptional activation of prpDC is required
for intracellular growth. BMDM were infected with
H37Rv or the D1129cmutant, and the cfu present
on Day 6 are presented as in (A).
(D) Mce4 mutants are relatively resistant to 3NP
treatment during intracellular growth. BMDMwere
infected with H37Rv or Dmce4 mutant bacteria in
the presence or absence of the indicated doses of
3NP. Intracellular cfu at Day 6 are plotted.
(E) Mce4 mutation partially suppresses the intra-
cellular growth defect of the DprpDC mutant.
The cfu detected after 6 days of intracellular
growth are presented. Each experiment in this
figure was performed at least twice. Representa-
tive experiments are shown in (A–D), and error
bars indicate standard deviation of triplicate or
quadruplicate samples. (E) represents the average
of three independent experiments. Statistical
significance was calculated by Student’s t test.
ns indicates p > .05. *p < .05. **p < .005.
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MCCmutant phenotype was reminiscent of strains lacking either
the hsaC gene (Yam et al., 2009) or the ‘‘igr’’ locus (Chang et al.,
2007; Chang et al., 2009) that encode functions dedicated to
earlier steps in cholesterol degradation. Like MCC mutants,
these strains are intoxicated in the presence of cholesterol and
are unable to grow in resting macrophages or acutely infected
animals. Together, these observations strongly argue that
M. tuberculosis obtains a significant amount of its carbon
requirements from cholesterol.
In contrast to their essentiality during intracellular growth in
macrophages, the prpDC genes have been found to be dispens-
able for bacterial growth in the mouse model of tuberculosis (TB)
(Mun˜oz-Elı´as et al., 2006). This observation was particularly
surprising, as cholesterol catabolism occurs throughout infec-
tion (Chang et al., 2009; Pandey and Sassetti, 2008; Yam et al.,
2009), and cell wall lipid alterations consistent with propionyl-
CoA assimilation are evident in bacteria isolated from mouse
tissue (Jain et al., 2007). This apparent contradiction could be
explained if the B12-dependent MMP was active under these
conditions, either because the bacterium acquires B12 from
the host or because some aspect of the host environment
stimulates B12 production by the pathogen (Savvi et al., 2008).
Our observation that B12 supplementation reverses the growth
defect of prpDC mutants in macrophages supports this
hypothesis.
This work highlights propionyl-CoA assimilation as a critical
feature ofM. tuberculosis metabolism in vivo and demonstrates
that this requirement is a direct result of the nutritional environ-
ment in the mycobacterial phagosome. However, even within224 Chemistry & Biology 19, 218–227, February 24, 2012 ª2012 Elsethis relatively isolated compartment, the bacterium is likely to co-
catabolize multiple carbon sources (de Carvalho et al., 2010),
and inhibiting the bacterium’s ability to utilize individual nutrients
is unlikely to represent a fruitful therapeutic strategy. In contrast,
inhibition of at least three distinct steps in cholesterol catabolism
(hsaC, igr, or MCC-encoding genes) results in metabolic toxicity
that might be effectively exploited to treat TB. Thus, a funda-
mental understanding of mycobacterial physiology during infec-
tion is critical for identifying vulnerabilities that can be used for
the rational design of more effective TB therapies.
SIGNIFICANCE
Mycobacterium tuberculosis replicates within a phago-
some-like compartment of the host macrophage, an envi-
ronment containing limited nutrients, low pH, and abundant
oxidative radicals. A number of central metabolic pathways
have been implicated in the adaptation to this niche, but the
basis for these requirements remained obscure. To under-
stand which of these metabolic adaptations could be attrib-
uted directly to the unique nutritional environment of the
phagosome, we identified metabolite pools that were
specifically altered during growth on cholesterol, a critical
carbon source during chronic infection. Themost significant
metabolite perturbation was the dramatic accumulation of
methylcitrate cycle (MCC) intermediates. We show that
these intermediates are produced during the catabolism of
propionyl-CoA derived from the terminal carbons of the
cholesterol side chain. Consistent with a requirement for
elevated MCC activity, growth on cholesterol required thevier Ltd All rights reserved
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genes, a function mediated by the Rv1129c protein. Using
a combination of genetic and chemical-genetic epistasis
analyses, we found that both Rv1129c and theMCCenzymes
were required for propionyl-CoA metabolism during intra-
cellular growth in macrophages and that a portion of this
metabolite was derived directly from cholesterol. Thus,
M. tuberculosis appears to satisfy a significant fraction of
its carbon requirement by scavenging host cholesterol,
and a coordinated transcriptional and metabolic adaptation
is necessary for the assimilation of propionyl-CoA liberated
by the catabolism of this compound.
EXPERIMENTAL PROCEDURES
Growth and Maintenance of Bacterial Strains
M. tuberculosiswas cultured in complete Middlebrook 7H9medium containing
0.05% Tween 80 and oleic acid-albumin-dextrose-catalase supplement.
Kanamycin, Hygromycin B, and Zeocin were used at 25, 50, and 25 mg/ml,
respectively. Forcholesterol experiments, bacteriaweregrown inminimalmedia
containing asparagine (0.5 g/l), KH2PO4 (1.0 g/l), Na2HPO4 (2.5 g/l), ferric ammo-
nium citrate (50 mg/l), MgSO4 $7H20 (0.5 g/l), CaCl2 (0.5 g/l), ZnSO4 (0.1 mg/),
0.2% tyloxapol, 0.2% ethanol, and either 0.1% glycerol or 0.01% cholesterol.
Where noted, Vitamin B12 (cyanocobalamin; Sigma) was added to a final
concentration of 10 mg/ml. Growth wasmonitored by optical density at 600 nm.
Genetic Manipulation of Strains
Drv1129c was generated in M. tuberculosis H37Rv by ‘‘recombineering’’ as
described elsewhere (van Kessel and Hatfull, 2007), except the recombination
functions were expressed from the pNIT::ET plasmid (GenBank No.
GU459073). Briefly, phage Che9c recombination genes were induced by over-
night incubation with 10 mM isovaleronitrile. Bacteria were then electroporated
with a linear substrate containing 500 bp of homology to both the upstream
and downstream regions of rv1129c flanking a hygromycin-resistance
cassette. The presence of both recombination junctions were verified by
PCR and sequencing. The absence of the rv1129c open reading frame was
also confirmed by PCR. Nucleotides 1253102-1254505 were deleted from
the genome. A complemented strain was generated by transforming the
mutant with pJEB402 (Guinn et al., 2004) containing full-length Rv1129c
sequence (nucleodides 1253074-1254564 in the H37Rv sequence) cloned
between HindIII and KpnI sites. This plasmid integrates in single copy into
the phage L5 attB site (Lee et al., 1991). The construction of icl1/2 mutants
in M. tuberculosis strain Erdman was described in (Mun˜oz-Elı´as and McKin-
ney, 2005). prpDC mutants were generated in H37Rv or an Dmce4 mutant of
H37Rv (Joshi et al., 2006), as described in (Mun˜oz-Elı´as et al., 2006).
Metabolomic Profiling
Strains were grown in quadruplicate in 50 ml of complete 7H9 medium until an
optical density at 600 nm (OD600) of 0.5 was reached. Cultures were then
washed in PBS twice and resuspended in minimal media with either 0.01%
cholesterol or 0.1% glycerol (Pandey and Sassetti, 2008) for 48 hr at 37C.
Cells were harvested at 4,000 g for 5 min at 4C and lysed by vortexing in
10 ml chloroform:methanol (2:1). We transferred samples to glass vials dried
under a stream of nitrogen and subjected to liquid chromatography/mass
spectrometry (LC/MS) analysis (in positive and negative ionization modes
independently) using a Thermo-Finnigan LTQ mass spectrometer essentially
as described elsewhere (Evans et al., 2009). We derivatized the same samples
with bistrimethyl-silyl-triflouroacetamide and subjected them to gas chroma-
tography/mass spectrometry (GC/MS) analysis using a Thermo-Finnigan
Trace DSQ fast-scanning single-quadrupole mass spectrometer with electron
impact ionization, as described by Lawton et al., 2008. All metabolite identities
listed in Table S1 were assigned by comparison to a library of mass/charge
(m/z), retention times, and MS/MS fragmentation spectra of authentic stan-
dards (Dehaven et al., 2010). GC/MS library spectra were also compared to
databases maintained by the National Institute of Standards and Technology.
All computational matches were confirmed by manual curation. RetentionChemistry & Biology 19, 218times and mass spectra for each metabolite are listed in Table S2. To conser-
vatively estimate the average relative abundance of metabolites that were
undetectable in one sample, we created a ‘‘median scaled imputed’’ data
set. In this transformation, the raw abundance value for each compound
was divided by the median of its detected values. Both raw and scaled data
sets are provided in Table S1. The ratios reported in Table S1 are based on
scaled data. We calculated p values from scaled data using Welch’s t test.
Metabolic Labeling and Lipid Analysis
Logarithmically growing cultures of H37Rv were collected by centrifugation and
resuspended in minimal medium containing 0.1 mCi/ml [26-14C]cholesterol or
[1,2-14C]acetate (American Radiolabeled Chemicals, St. Louis, MO, USA).
Labeling was performed for 16 hr. Cell pellets were washed twice with PBS
and extractedwith chloroform:methanol (2:1). Extractswere dried under nitrogen
and resolved by thin layer chromatography using glass-baked silica gel plates
(250 mmthick) using a chloroform:methanol:water (60:30:6)mobile phase.Radio-
labeled species were detected with a phosphorimager. To identify and charac-
terize SL-1, we excised the region of the TLC plate containing this species and
subjected it to mass spectrometry in negative ion mode using a quadrupole
time-of-flight (Q-Tof) mass spectrometer equipped with a Z-spray electrospray
ionization (ESI) source (Q-TOF Premier; Waters Corporation, Milford, MA, USA).
Macrophage Infections
We isolated BMDMs from C57BL/6 mice by culturing bone marrow cells in
Dulbecco’s modified Eagle’s medium containing 10% fetal bovine serum,
2 mM glutamine, 10% L929-conditioned medium, and 10 mg/ml ciprofloxacin
for 5 days. Animal manipulations were performed under the oversight of the
University of Massachusetts Institutional Animal Care and Use Committee.
Sixteen hours before infection, differentiated BMDMs were seeded on a
24-well tissue culture plate at 53 105 cells per well in the samemedium lacking
antibiotic. Macrophages were infected with different strains ofM. tuberculosis
at a multiplicity of infection of 1 for 4 hr at 37C. Extracellular bacteria were
removed by washing three times with warm PBS. Intracellular bacteria were
quantified by lysing the cells with PBS containing 1% Triton X-100 at the
indicated time points and plating dilutions on 7H10 agar. 3-NP or vitamin
B12 was added at the indicated concentrations at the time of inoculation
and maintained throughout the infection.
Quantitative PCR
Bacterial strains were grown in complete 7H9medium until log phase, washed
twice in PBS, and cultured in minimal medium with either 0.01% cholesterol or
0.1% glycerol for 48 hr at 37C. Bacteria were collected by centrifugation, re-
suspended in Trizol, and lysed by bead beating. RNA was isolated according
to the manufacturer’s directions and treated with DNase (TURBO DNA-free
Kit; Applied Biosystems, Foster City, CA, USA). cDNA was generated with
equal amounts of RNA from all samples (SMARTScribe Reverse Transcriptase;
Clontech, Mountain View, CA, USA). We conducted quantitative PCR using iQ
SYBR Green Supermix from BioRad and the following PCR parameters: 95C
for 10 min; 40 cycles of 95C for 30 s; 62C for 30 s; 72C for 30 s; read plate,
76C for 2 s; read plate, 78C for 2 s; read plate, 80C for 2 s; read plate, 81C
for 2 s; then read plate 72C for 1 min. PCR primers were as follows:
50-TGACTTTCACGACACGTTTCTGGC-30 for prpD forward; 50-TGTGGATCT
CATAGGCGGTTACCA-30 for prpD reverse; 50-ATGGCTGGACATCTACCA
GGTGTT-30 for prpC forward; and 50-TGTCGAATCCCATCAGGTAGTACG-30
for prpC reverse. We calculated relative abundance of message by comparing
all amounts for each gene relative to a standard curve from the H37Rv strain in
cholesterol for the corresponding gene. The quantity of cDNA in each sample
was normalized to the sigA mRNA.
SUPPLEMENTAL INFORMATION
Supplemental Information includes two tables and and can be found with this
article online at doi:10.1016/j.chembiol.2011.12.016.
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